PREGNANCY IN WOMEN WITH CHRONIC KIDNEY DISEASE OF ALL STAGES, INCLUDING WOMEN ON DIALYSIS AND WITH KIDNEY TRANSPLANTS
With
Professor Shilpanjali Jesudason
Head of Unit, Central and Northern Adelaide Renal and Transplantation Service (CNARTS),
Royal Adelaide Hospital,
Central Adelaide Local Health Network (CALHN) &
Clinical Professor, University of Adelaide, South Australia
RESEARCHER PROFILE
Filmed in Adelaide, South Australia | March 2025
Professor Shilpanjali Jesudason is an academic nephrologist and Head of Department at the Royal Adelaide Hospital’s Central Northern Adelaide Renal and Transplant Service, South Australia.
From 2017-2020, she was the Clinical Director of Kidney Health Australia, the peak body for patients with kidney disease. In this role she developed a passion for advancing kidney disease education in primary care.
She is the founder and Program Lead for Pregnancy and Kidney Research Australia, co-leads the new ISN Train the Trainer Program for Pregnancy and Kidney Disease, and is the inaugural chair of the Australian and Zealand Dialysis and Transplantation Registry (ANZDATA) Parenthood working group.
She is founding chair of the ANZ Society of Nephrology Pacific Working Group, and has been a supporter of nephrology development in her birth country of Fiji.
In 2025, she was awarded the Roscoe R. Robinson award for outstanding contributions to nephrology, by the International Society of Nephrology.
https://orcid.org/0000-0001-9695-0761
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Risk factors and prevention of respiratory infections and infectious diseases in children
A/Prof Hannah Moore OAM is an infectious disease epidemiologist; Co-Head of the Infectious Disease Epidemiology team within the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia and Associate Professor at the School of Population Health, Curtin University in Western Australia.
A/Prof Moore has been awarded more than $19M in competitive research grants, co-authored more than 140 papers, was TEDxPerth 2018 speaker, recipient of a WA Young Tall Poppy Award (2013) and the WA Premiers Science Early Career Scientist Award (2015). In 2024, she was honoured with a Medal of the Order of Australia for her service to epidemiology as a researcher.
-
Professor Matthew Kiernan
BRAIN AND MIND CENTRE
@ UNIVERSITY OF SYDNEY, NEW SOUTH WALES AUSTRALIA
